Bioelectrical impedance phase angle in clinical practice: implications for prognosis in stage IIIB and IV non-small cell lung cancer

Digant Gupta, Carolyn A Lammersfeld, Pankaj G Vashi, Jessica King, Sadie L Dahlk, James F Grutsch, Christopher G Lis, Digant Gupta, Carolyn A Lammersfeld, Pankaj G Vashi, Jessica King, Sadie L Dahlk, James F Grutsch, Christopher G Lis

Abstract

Background: A frequent manifestation of advanced lung cancer is malnutrition, timely identification and treatment of which can lead to improved patient outcomes. Bioelectrical impedance analysis (BIA) is an easy-to-use and non-invasive technique to evaluate changes in body composition and nutritional status. We investigated the prognostic role of BIA-derived phase angle in advanced non-small cell lung cancer (NSCLC).

Methods: A case series of 165 stages IIIB and IV NSCLC patients treated at our center. The Kaplan Meier method was used to calculate survival. Cox proportional hazard models were constructed to evaluate the prognostic effect of phase angle, independent of stage at diagnosis and prior treatment history.

Results: 93 were males and 72 females. 61 had stage IIIB disease at diagnosis while 104 had stage IV. The median phase angle was 5.3 degrees (range = 2.9 - 8). Patients with phase angle <or= 5.3 had a median survival of 7.6 months (95% CI: 4.7 to 9.5; n = 81), while those with > 5.3 had 12.4 months (95% CI: 10.5 to 18.7; n = 84); (p = 0.02). After adjusting for age, stage at diagnosis and prior treatment history we found that every one degree increase in phase angle was associated with a relative risk of 0.79 (95% CI: 0.64 to 0.97, P = 0.02).

Conclusion: We found BIA-derived phase angle to be an independent prognostic indicator in patients with stage IIIB and IV NSCLC. Nutritional interventions targeted at improving phase angle could potentially lead to an improved survival in patients with advanced NSCLC.

Figures

Figure 1
Figure 1
A histogram depicting the distribution of phase angle.
Figure 2
Figure 2
Survival stratified by phase angle categories with cutoff of 5.3. Each drop in a probability curve indicates one or more events in that group. Vertical lines indicate censored patients, i.e., those who reached the end of their follow-up without experiencing death.

References

    1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108. doi: 10.3322/canjclin.55.2.74.
    1. Sarhill N, Mahmoud FA, Christie R, Tahir A. Assessment of nutritional status and fluid deficits in advanced cancer. Am J Hosp Palliat Care. 2003;20:465–473. doi: 10.1177/104990910302000610.
    1. Barbosa-Silva MC, Barros AJ, Post CL, Waitzberg DL, Heymsfield SB. Can bioelectrical impedance analysis identify malnutrition in preoperative nutrition assessment? Nutrition. 2003;19:422–426. doi: 10.1016/S0899-9007(02)00932-2.
    1. Cox-Reijven PL, van Kreel B, Soeters PB. Bioelectrical impedance measurements in patients with gastrointestinal disease: validation of the spectrum approach and a comparison of different methods for screening for nutritional depletion. Am J Clin Nutr. 2003;78:1111–1119.
    1. Fredrix EW, Saris WH, Soeters PB, Wouters EF, Kester AD, von Meyenfeldt MF, Westerterp KR. Estimation of body composition by bioelectrical impedance in cancer patients. Eur J Clin Nutr. 1990;44:749–752.
    1. Kushner RF. Bioelectrical impedance analysis: a review of principles and applications. J Am Coll Nutr. 1992;11:199–209.
    1. Bauer J, Capra S, Ferguson M. Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr. 2002;56:779–785. doi: 10.1038/sj.ejcn.1601412.
    1. Carney DE, Meguid MM. Current concepts in nutritional assessment. Arch Surg. 2002;137:42–45. doi: 10.1001/archsurg.137.1.42.
    1. Waitzberg DL, Correia MI. Nutritional assessment in the hospitalized patient. Curr Opin Clin Nutr Metab Care. 2003;6:531–538. doi: 10.1097/00075197-200309000-00006.
    1. Detsky AS, Baker JP, Mendelson RA, Wolman SL, Wesson DE, Jeejeebhoy KN. Evaluating the accuracy of nutritional assessment techniques applied to hospitalized patients: methodology and comparisons. JPEN J Parenter Enteral Nutr. 1984;8:153–159. doi: 10.1177/0148607184008002153.
    1. Nagano M, Suita S, Yamanouchi T. The validity of bioelectrical impedance phase angle for nutritional assessment in children. J Pediatr Surg. 2000;35:1035–1039. doi: 10.1053/jpsu.2000.7766.
    1. Marken Lichtenbelt WD, Westerterp KR, Wouters L, Luijendijk SC. Validation of bioelectrical-impedance measurements as a method to estimate body-water compartments. Am J Clin Nutr. 1994;60:159–166.
    1. Desport JC, Preux PM, Bouteloup-Demange C, Clavelou P, Beaufrere B, Bonnet C, Couratier PP. Validation of bioelectrical impedance analysis in patients with amyotrophic lateral sclerosis. Am J Clin Nutr. 2003;77:1179–1185.
    1. Adami GF, Marinari G, Gandolfo P, Cocchi F, Friedman D, Scopinaro N. The use of bioelectrical impedance analysis for monitoring body composition changes during nutritional support. Surg Today. 1993;23:867–870. doi: 10.1007/BF00311363.
    1. Azcue M, Fried M, Pencharz PB. Use of bioelectrical impedance analysis to measure total body water in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 1993;16:440–445.
    1. Chertow GM, Lowrie EG, Wilmore DW, Gonzalez J, Lew NL, Ling J, Leboff MS, Gottlieb MN, Huang W, Zebrowski B. Nutritional assessment with bioelectrical impedance analysis in maintenance hemodialysis patients. J Am Soc Nephrol. 1995;6:75–81.
    1. Fein PA, Gundumalla G, Jorden A, Matza B, Chattopadhyay J, Avram MM. Usefulness of bioelectrical impedance analysis in monitoring nutrition status and survival of peritoneal dialysis patients. Adv Perit Dial. 2002;18:195–199.
    1. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr. 1985;41:810–817.
    1. Pencharz PB, Azcue M. Use of bioelectrical impedance analysis measurements in the clinical management of malnutrition. Am J Clin Nutr. 1996;64:485S–488S.
    1. Pupim LB, Kent P, Ikizler TA. Bioelectrical impedance analysis in dialysis patients. Miner Electrolyte Metab. 1999;25:400–406. doi: 10.1159/000057482.
    1. Simons JP, Schols AM, Westerterp KR, ten Velde GP, Wouters EF. The use of bioelectrical impedance analysis to predict total body water in patients with cancer cachexia. Am J Clin Nutr. 1995;61:741–745.
    1. Zarowitz BJ, Pilla AM. Bioelectrical impedance in clinical practice. DICP. 1989;23:548–555.
    1. Barbosa-Silva MC, Barros AJ. Bioelectrical impedance analysis in clinical practice: a new perspective on its use beyond body composition equations. Curr Opin Clin Nutr Metab Care. 2005;8:311–317.
    1. Baumgartner RN, Chumlea WC, Roche AF. Bioelectric impedance phase angle and body composition. Am J Clin Nutr. 1988;48:16–23.
    1. Selberg O, Selberg D. Norms and correlates of bioimpedance phase angle in healthy human subjects, hospitalized patients, and patients with liver cirrhosis. Eur J Appl Physiol. 2002;86:509–516. doi: 10.1007/s00421-001-0570-4.
    1. Faisy C, Rabbat A, Kouchakji B, Laaban JP. Bioelectrical impedance analysis in estimating nutritional status and outcome of patients with chronic obstructive pulmonary disease and acute respiratory failure. Intensive Care Med. 2000;26:518–525. doi: 10.1007/s001340051198.
    1. Maggiore Q, Nigrelli S, Ciccarelli C, Grimaldi C, Rossi GA, Michelassi C. Nutritional and prognostic correlates of bioimpedance indexes in hemodialysis patients. Kidney Int. 1996;50:2103–2108. doi: 10.1038/ki.1996.535.
    1. Ott M, Fischer H, Polat H, Helm EB, Frenz M, Caspary WF, Lembcke B. Bioelectrical impedance analysis as a predictor of survival in patients with human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;9:20–25.
    1. Schwenk A, Ward LC, Elia M, Scott GM. Bioelectrical impedance analysis predicts outcome in patients with suspected bacteremia. Infection. 1998;26:277–282. doi: 10.1007/BF02962247.
    1. Schwenk A, Beisenherz A, Romer K, Kremer G, Salzberger B, Elia M. Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment. Am J Clin Nutr. 2000;72:496–501.
    1. Gupta D, Lis CG, Dahlk SL, Vashi PG, Grutsch JF, Lammersfeld CA. Bioelectrical impedance phase angle as a prognostic indicator in advanced pancreatic cancer. Br J Nutr. 2004;92:957–962. doi: 10.1079/BJN20041292.
    1. Gupta D, Lammersfeld CA, Burrows JL, Dahlk SL, Vashi PG, Grutsch JF, Hoffman S, Lis CG. Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer. Am J Clin Nutr. 2004;80:1634–1638.
    1. Gupta D, Lammersfeld CA, Vashi PG, King J, Dahlk SL, Grutsch JF, Lis CG. Bioelectrical impedance phase angle as a prognostic indicator in breast cancer. BMC Cancer. 2008;8:249. doi: 10.1186/1471-2407-8-249.
    1. Toso S, Piccoli A, Gusella M, Menon D, Bononi A, Crepaldi G, Ferrazzi E. Altered tissue electric properties in lung cancer patients as detected by bioelectric impedance vector analysis. Nutrition. 2000;16:120–124. doi: 10.1016/S0899-9007(99)00230-0.
    1. Elia M. The bioimpedance 'craze'. Eur J Clin Nutr. 1993;47:825–827.
    1. Lukaski HC. Requirements for clinical use of bioelectrical impedance analysis (BIA) Ann N Y Acad Sci. 1999;20;873:72–76. doi: 10.1111/j.1749-6632.1999.tb09451.x.
    1. Dittmar M. Reliability and variability of bioimpedance measures in normal adults: effects of age, gender, and body mass. Am J Phys Anthropol. 2003;122:361–370. doi: 10.1002/ajpa.10301.
    1. Foster KR, Lukaski HC. Whole-body impedance – what does it measure? Am J Clin Nutr. 1996;64:388S–396S.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する